Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Analyst Rating Guide

News

Back

Clearside Biomedical Q4 2023 Adj EPS $(0.08) Beats $(0.09) Estimate, Sales $6.30M Beat $4.43M Estimate

Author: Benzinga Newsdesk | March 12, 2024 04:17pm

Clearside Biomedical (NASDAQ:CLSD) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.09) by 11.11 percent. The company reported quarterly sales of $6.30 million which beat the analyst consensus estimate of $4.43 million by 42.11 percent. This is a 1.81K percent increase over sales of $330.00 thousand the same period last year.

Posted In: CLSD